Expressing the specificity and the potency of cytochrome P-450 inducers toward 7-ethoxyresorufin
Paolini, M.; Forti, G.C.; Bauer, C.
Drug Metabolism and Disposition the Biological Fate of Chemicals 18(5): 551
1990
ISSN/ISBN: 0090-9556 PMID: 1981700 Document Number: 348912
Document emailed within 1 workday
Related Documents
Roberts, E.A.; Xie, Z.W.; Yang, S.; Lipa, J. 1993: Inducibility of enzyme activities associated with the cytochrome P-450 1A family, ethoxyresorufin O-deethylase, and methoxyresorufin O-demethylase in human hepatocyte lines derived from normal liver tissue Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(1): 56-61Kuz'mitskiĭ, B.B.; Dad'kov, I.G.; Mashkovich, A.E.; Stoma, O.V.; Slepneva, L.M. 1990: Immunomodulators with an 8-azasteroid structure as inducers of liver cytochrome P-450 Farmakologiia i Toksikologiia 53(2): 52-55
Morgan, E.T.; Norman, C.A. 1990: Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(5): 649-653
Khakimov, Z.Z.; Rakhmanov, A.K. 1992: The efficacy of hepatoprotectors and cytochrome P-450 inducers in correcting the functional activity of the hepatocyte microsomal system in an acute lesion of the liver in prepuberty Eksperimental'naia i Klinicheskaia Farmakologiia 55(4): 16-17
Pichard, L.; Fabre, J.M.; Domergue, J.; Fabre, G.; Saint-Aubert, B.; Mourad, G.; Maurel, P. 1991: Molecular mechanism of cyclosporine a drug interactions: inducers and inhibitors of cytochrome P450 screening in primary cultures of human hepatocytes Transplantation Proceedings 23(1 Part 2): 978-979
Calvo, V.; Rojo, S.; Aparicio, P.; Galocha, B.; López de Castro, J.A. 1988: Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen Journal of Immunology 141(11): 3798-3803
Mamula, M.J.; Jemmerson, R.; Hardin, J.A. 1990: The specificity of human anti-cytochrome c autoantibodies that arise in autoimmune disease Journal of Immunology 144(5): 1835-1840
Nishi, K.; Akaike, N.; Oyama, Y.; Ito, H. 1983: Actions of calcium antagonists on calcium currents in Helix neurons. Specificity and potency Circulation Research 52(2 Part 2): I53-I59
Tassaneeyakul, W.; Birkett, D.J.; Edwards, J.W.; Veronese, M.E.; Tassaneeyakul, W.; Tukey, R.H.; Miners, J.O. 1996: Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene Journal of Pharmacology and Experimental Therapeutics 276(1): 101-108
Kharasch, E.D.; Hankins, D.C.; Jubert, C.; Thummel, K.E.; Taraday, J.K. 1999: Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1 Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(6): 717-723
McManus, M.E.; Burgess, W.; Snyderwine, E.; Stupans, I. 1988: Specificity of rabbit cytochrome P-450 isozymes involved in the metabolic activation of the food derived mutagen 2-amino-3-methylimidazo[4,5-f] quinoline Cancer Research 48(16): 4513-4519
Kim, C.H.; King, T.E. 1991: Effect of pyridoxal phosphate on the formation of cytochrome c1-c and cytochrome c-cytochrome oxidase complexes Biochemistry International 24(2): 255-262
Mendelsohn, L.G.; Johnson, B.G.; Scott, W.L.; Frederickson, R.C. 1985: Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo Journal of Pharmacology and Experimental Therapeutics 234(2): 386-390
Kilkenny, A.E.; Morgan, D.; Spangler, E.F.; Yuspa, S.H. 1985: Correlation of initiating potency of skin carcinogens with potency to induce resistance to terminal differentiation in cultured mouse keratinocytes Cancer Research 45(5): 2219-2225
Rohde, K.; Blanck, J.; Ruckpaul, K. 1983: Kinetics of elementary steps in the cytochrome P-450 reaction sequence. VI. Model treatment of the NADPH-dependent first electron transfer reaction between cytochrome P-450 reductase and cytochrome P-450 LM2 in solution Biomedica Biochimica Acta 42(6): 651-662
Burke, M.D.; Mayer, R.T. 1975: Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation Drug Metabolism and Disposition: the Biological Fate of Chemicals 3(4): 245-253
Pacifici, G.M.; Park, S.S.; Gelboin, H.V.; Rane, A. 1988: 7-Ethoxycoumarin and 7-ethoxyresorufin O-deethylase in human foetal and adult liver: studies with monoclonal antibodies Pharmacology and Toxicology 63(1): 26-29
Gorsky, L.D.; Coon, M.J. 1986: Effects of conditions for reconstitution with cytochrome b5 on the formation of products in cytochrome P-450-catalyzed reactions Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(1): 89-96
Grishanova, A.Iu.; Mishin, V.M.; Liakhovich, V.V. 1985: Interaction between cytochrome P-448 and NADP-cytochrome P-450 reductase in reconstituted microsomal membranes Biokhimiia 50(3): 369-374
Yasui, N. 1996: The relationship between single-oral dose kinetics of alprazolam and cytochrome P4503A and cytochrome P4502C19 Nihon Shinkei Seishin Yakurigaku Zasshi 16(3): 109-112